Skip to main content
. 2024 Dec;40(11):2495–2501. doi: 10.12669/pjms.40.11.9360

Table-I.

Comparison of baseline and clinical characteristics among bacteremia and non-bacteremia groups

Patient characteristics Total (n=100) Bacteremia (n=19) Non-bacteremia (n=81) P-value
Age
Less than 40 years 45 9 36 0.818
Greater than 40 years 55 10 45
Gender
Female 57 8 35 0.930
Male 43 11 46
Disease classification
SJS 70 10 60
TEN 18 4 14 0.077
SJS and TEN overlap 12 5 7
Past medical history
Hypertension 39 7 32 0.830
Diabetes 22 5 17 0.614
Neuro-psychiatric illness 17 4 13 0.601
Chronic Kidney Disease 10 4 6 0.074
Ischemic Heart Disease 9 4 5 0.041
Malignancy 4 2 2 0.162
Respiratory Disease 3 2 1 0.033
Autoimmune diseases 2 0 2 0.489
Endocrine diseases 1 0 1 0.626
Chronic liver diseases 1 0 1 0.626
Prior history of SJS 3 0 3 0.528
Clinical manifestation
No sepsis 8 0 8
Sepsis 73 9 64 <0.001
Septic Shock 19 10 9
Positive history of precipitating drug use 67 14 53 0.378
SCORTEN score 0.040
Less than 4 76 11 65
Equal to or more than 4 24 8 16
ICU admission 12 7 5 <0.001
Complications
Electrolyte imbalance 56 17 39 0.001
Acute kidney injury 43 11 32 0.145
Liver injury 40 12 28 0.026
Deranged coagulation 20 11 9 <0.001
Elevated troponin 13 6 7 0.007
Infective parameters [Median (IQR)]
C-reactive protein (ug/mL) 12.7 (4.2-17.4) 13.7 (4.6-19.0) 12.0 (3.9-16.9) 0.411
Procalcitonin (ng/mL) 1.1 (0.2-6.4) 9.7 (0.9-35.7) 0.4 (0.1-2.8) 0.007
Length of stay
Less than 7 days 67 12 55
Equal or more than 7 days 33 7 26 0.692
Outcome
Discharged 81 9 72
Expired 15 9 6 <0.001
LAMA 4 1 3